home

GLMD.US | summary | financial summary | prediction chart | global stock news | news graph | volatility | components |pairs | earnings | dividends | sales | compare

symbollastchange%chngnamemcapsectorwiki
GLMD
US
Galmed Pharmaceuticals Ltd

Market global news for GLMD (US) Galmed Pharmaceuticals Ltd

Global news - US chevrons indicate local prediction, arrows show global predictions
Today
previous days
Galmed Pharmaceuticals (NASDAQ:GLMD) Now Covered by StockNews.com
tickerreport - 07:00 Mon 25 - GLMD - link story
MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor
prnewswire - 15:30 Thu 21 - GLMD - link story
MIRA Pharmaceuticals Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor
marketscreener - 15:30 Thu 21 - GLMD - link story
Mira Pharma (MIRA) Welcomes Dr. Itzchak Angel, former Head of Pharmacology at Synthelabo, as Chief Scientific Advisor
streetinsider - 15:30 Thu 21 - GLMD - link story
Galmed Pharmaceutica Stock Quote | Stock Price for GLMD | FinancialContent Business Page
financialcontent - 10:15 Sun 17 - GLMD - link story
Galmed Granted European Patent For Use Of Aramchol-Resmetirom To Treat NASH/MASH, Liver Fibrosis
rttnews - 15:00 Fri 15 - GLMD - link story
Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis
lelezard - 14:45 Fri 15 - GLMD - link story
Galmed Announces Grant of New Patent for the Combination of Aramchol with Resmetirom (MGL-3196, REZDIFFRA) for the Treatment of NASH and Liver Fibrosis
marketscreener - 13:30 Fri 15 - GLMD - link story
Galmed Pharmaceuticals (NASDAQ:GLMD) Earns Sell Rating from Analysts at StockNews.com
wkrb13 - 09:00 Fri 23 - GLMD - link story